octopamine has been researched along with Heart Failure in 5 studies
Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, the roles of MMP-2, MMP-9, MT1-MMP, focal adhesion kinase (FAK), and Paxillin in hearts of early multiple organ failure induced by norfenefrine-masked hypovolemia and endotoxemia were investigated in an ovine model." | 3.73 | Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. ( Baba, HA; Hinder, F; Kawaguchi, N; Schmitz, KJ; Stubbe, HD; Takeda, A; Takeda, N; Wohlschlaeger, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KLEEMANN, U | 2 |
| HERBERG, D | 1 |
| Wohlschlaeger, J | 1 |
| Stubbe, HD | 1 |
| Schmitz, KJ | 1 |
| Kawaguchi, N | 1 |
| Takeda, A | 1 |
| Takeda, N | 1 |
| Hinder, F | 1 |
| Baba, HA | 1 |
| Zschornack, MR | 1 |
| Haller, H | 1 |
| Ohlenschläger, G | 1 |
| Schwalbe, J | 1 |
5 other studies available for octopamine and Heart Failure
| Article | Year |
|---|---|
[Contribution to the management of acute circulatory failure in internal medicine with novadral].
Topics: Disease Management; Heart Failure; Humans; Internal Medicine; Octopamine; Shock; Sympathomimetics | 1956 |
[Contribution to the management of acute circulatory failure in internal medicine with novadral].
Topics: Disease Management; Heart Failure; Humans; Internal Medicine; Octopamine; Shock; Sympathomimetics | 1956 |
[Contribution to the management of acute circulatory failure in internal medicine with novadral].
Topics: Disease Management; Heart Failure; Humans; Internal Medicine; Octopamine; Shock; Sympathomimetics | 1956 |
[Contribution to the management of acute circulatory failure in internal medicine with novadral].
Topics: Disease Management; Heart Failure; Humans; Internal Medicine; Octopamine; Shock; Sympathomimetics | 1956 |
[ACUTE COR PULMONALE].
Topics: Angiotensins; Atropine; Deoxyribonuclease I; Drug Therapy; Electrocardiography; Heart Failure; Hepar | 1965 |
Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model.
Topics: Animals; Apoptosis; Cardiomyopathies; Disease Models, Animal; Endotoxemia; Heart; Heart Failure; Hyp | 2005 |
[Directives on the treatment of diabetic coma with special reference to disorders of the water-electrolyte balance. 2].
Topics: Anuria; Carbohydrate Metabolism; Carbonates; Diabetic Coma; Diabetic Ketoacidosis; Heart Failure; Hu | 1965 |
[Treatment of light to medium severe heart insufficiency with a combined preparation Stabilocard].
Topics: Heart Failure; Humans; Octopamine; Phytotherapy; Plants, Medicinal; Strophanthins; Theophylline | 1966 |